Automated Measurement of Adherence to Traumatic Brain Injury (TBI) Guidelines using Neurological ICU Data by Stell, Anthony et al.
Automated Measurement of Adherence to Traumatic Brain Injury 
(TBI) Guidelines using Neurological ICU Data 
Anthony Stell, Ian Piper and Laura Moss 
Department of Clinical Physics, University of Glasgow, Glasgow, U.K. 
 
Keywords: Guideline Adherence, Process Models, Similarity Calculations. 
Abstract: Using a combination of physiological and treatment information from neurological ICU data-sets, adherence 
to traumatic brain injury (TBI) guidelines on hypotension, intracranial pressure (ICP) and cerebral perfusion 
pressure (CPP) is calculated automatically. The ICU output is evaluated to capture pressure events and 
actions taken by clinical staff for patient management, and are then re-expressed as simplified process 
models. The official TBI guidelines from the Brain Trauma Foundation are similarly evaluated, so the two 
structures can be compared and a quantifiable distance between the two calculated (the measure of 
adherence). The methods used include: the compilation of physiological and treatment information into 
event logs and subsequently process models; the expression of the BTF guidelines in process models within 
the real-time context of the ICU; a calculation of distance between the two processes using two algorithms 
(“Direct” and “Weighted”) building on work conducted in the business process domain. Results are 
presented across two categories each with clinical utility (minute-by-minute and single patient stays) using a 
real ICU data-set. Results of two sample patients using a weighted algorithm show a non-adherence level of 
6.25% for 42 mins and 56.25% for 708 mins and non-adherence of 18.75% for 17 minutes and 56.25% for 
483 minutes. Expressed as two combinatorial metrics (duration/non-adherence (A) and duration * non-
adherence (B)), which together indicate the clinical importance of the non-adherence, one has a mean of 
A=4.63 and B=10014.16 and the other a mean of A=0.43 and B=500.0. 
1 INTRODUCTION 
Across many fields of clinical medicine guidelines 
are used to inform and develop best practice. In 
order to make sure that these guidelines are being 
followed correctly and effectively, there are a 
variety of methods to monitor compliance. Common 
current methods to do this include post-hoc surveys 
that form the core data for research papers, or 
regular meetings after a hospital shift (or similar) to 
discuss different cases where perhaps the guideline 
was not adhered to, or negative outcomes were 
potentially avoidable. 
Nearly all current methods have two features: 
qualitative evaluation and a long time-lag where the 
results of the surveys or discussion can find their 
way back into either local best practice, or can be 
submitted to multi-centre evaluations for the further 
development of the guidelines themselves. Whilst 
useful, it is very often the case that these features do 
not make full use of the data and technology that is 
now available to many fields of clinical medicine. A 
potential advantage of using such data and 
technology would be quantitative evaluations (e.g. 
an adherence rate of 67%) and rapid feedback of 
non-compliance to guidelines.  
This work attempts to leverage those 
advantages by providing a “near real-time” ability to 
monitor clinical guideline adherence, as well as 
providing measurable quantitative feedback. Using 
data and technology currently available, the goal of 
this research is to express the structure of 
physiological and treatment patient data in such a 
way that can be immediately compared against best-
practice text guidelines. The results are broadly 
grouped into two categories, each representing a 
real-life clinical scenario: 
▪ Minute-by-minute data: where immediate 
feedback would be provided indicating the level 
of adherence in that moment 
▪ Per pressure event: where retrospective 
guidance on adherence could provide 
information on the best way to manage 
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individual pressure events given a patient’s 
particular clinical context 
The technical approach adopted to achieve these 
goals is a combination of the following: the 
expression of the two data types (physiological and 
treatment) into a simplified process model; the 
expression of the relevant text guidelines into a 
comparable structure; a distance between these two 
models is then evaluated using similarity 
calculations taken from the domain of business 
process model comparisons (Dijkman et al. 2009). 
2 MOTIVATION 
There are two main areas that provide the relevant 
background to this work: the nature of data within 
critical care – traumatic brain injury (TBI) in 
particular – and the detail of the technology chosen 
to support the solution of automated guideline 
adherence. 
2.1 Critical Care Data 
In the fields of medicine that involve critical care – 
traumatic brain injury (TBI) as an example – 
technology has advanced throughout the late 20th 
and early 21st centuries to the point where nearly 
every modern intensive care unit (ICU) in the 
developed world has a multitude of high frequency 
data streams available, which can closely capture the 
actual application of clinical interventions and the 
time-varying physiological response of patients.  
The technologies that enable this output of raw 
data are well established, and the economics of data 
storage make retention of large volumes for 
extended periods a feasible option. However, the key 
to establishing the integrity of that data for a specific 
purpose – whether it is a study as large as a multi-
centre randomised controlled trial (RCT) or 
something more modest such as an audit of local 
clinical practices – is to monitor that raw data and 
understand the relationships between clinical 
treatments and physiological output. 
This involves understanding that relationship at a 
level “above” the numbers that are output from 
bedside machines (other terminology may similarly 
describe this idea as observing data at a higher 
“layer of abstraction”). The actual physiological 
output shows a series of numbers, which without 
proper context can mean very little, but which, with 
appropriate surrounding information, could be 
formed into structures that do have clinical meaning 
(e.g. an “adverse event” such as a sudden spike in 
blood pressure would be represented by a particular 
combination of systolic and diastolic blood pressure 
numbers). When this is combined with clinical 
treatment information (e.g. the time and dose of a 
bolus of Noradrenaline) then patterns of clinical 
behaviour and patient response can be built up. 
If the algorithms used to represent these patterns 
of information are valid, then – due to the proximity 
of this data representation to the source – it is likely 
that it will be a highly accurate description of what 
happens in an ICU. And therefore in theory, it would 
be possible for a system to work out – empirically 
from source – whether a specific clinical process in 
the ICU has been followed or not. 
Very often, the most important and highly-
valued process within any clinical field is that of the 
official guidelines compiled and peer-reviewed by 
domain experts. Therefore an automated process to 
measure adherence to these guidelines would very 
likely be welcome due to the information it could 
provide on procedure, compliance and base-line 
information for studies to either build upon or 
challenge those guidelines. For instance, questions 
that could be asked of the system could be: 
 
1) “Has a particular protocol or guideline been 
applied correctly?” (to audit local compliance) 
2) “Does a particular guideline recommendation 
actually work?” (use outcome versus 
compliance data to provide information to a 
wider study) 
Whilst it is hoped that solutions to this type of 
guideline adherence measurement could be applied 
to critical care generally, the area of traumatic brain 
injury (TBI) – and within TBI specifically the 
management of intra-cranial pressure (ICP) and 
cerebral perfusion pressure (CPP) - has many 
features that make it a good candidate for study: the 
condition is complex and therefore suffers from 
large uncertainties in official guideline compilation 
and compliance (Bullock et al. 1996); it is also an 
environment that heavily uses modern technology to 
provide high-resolution neuro-ICU physiological 
and clinical treatment data streams (Piper et al. 
2009); and the seriousness and prevalence of the 
condition (www.headway.org.uk) means that any 
advances in the field have the potential to make a 
large and positive impact on the population.  
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2.2 Applied Technology 
Based on the considerations above concerning 
critical care data, the general technical data 
requirements to achieve this can be identified as 
follows: 
▪ High resolution physiological patient data 
▪ Accurate and comprehensive treatment data 
▪ The ability to combine these into a formalised 
process expression 
▪ The ability to compare this formalised 
expression with other similar entities (such as 
guidelines, study protocols, institutional 
procedure, etc) 
Whilst the pool of potential technological 
solutions for this type of problem space is large, the 
following criteria – after accuracy and validity – 
were deemed the most important when choosing a 
solution: 
▪ Simplicity of implementation 
▪ Minimising points of “assumed knowledge” 
▪ Correspondence of solution output with real 
clinical situations 
▪ The ability to inhabit a real clinical work-flow 
“invisibly” 
After researching different technologies that 
potentially meet these criteria, the following 
combination of processes was put together as a 
framework: 
▪ The classification of events in physiological 
output known as EUSIG events (Edinburgh 
University Secondary Insult Grade) (Jones et al. 
1994), and compilation of an event log from this 
▪ The expression of those event logs as process 
models 
▪ The extraction of clinical guideline texts into 
process models 
▪ The comparison of two process models using 
complex similarity/distance algorithms 
Together, these processes form the framework 
through which the possibility of quantitative, real-
time guideline adherence monitoring can be 
explored. Figure 1 shows a high-level schematic of 
the framework steps to convert ICU data and 
guideline text into comparable data-sets. 
Examining these processes in more detail, event 
detection and representation are common methods of 
data analysis in medicine.  
 
 
 
 
Figure 1: High-level schematic of guideline adherence 
system design. 
The classification of pressure events using 
EUSIG parameters has a well-established precedent, 
particularly in the field of TBI (Jones et al. 1994). 
The central idea behind this step is that an event can 
be classified as having several EUSIG “parameters” 
– e.g. event hold-down, threshold, duration – then 
this pattern is searched for in the physiological data. 
Once an event is found, a time-window is laid over it 
and clinical treatment events are searched for (figure 
2 shows a schematic of a EUSIG event pattern). The 
full detail of the conversion of the data-sets used in 
this work from raw physiological and treatment 
output to their corresponding event logs can be 
found in (Stell et al. 2014). 
 
Figure 2: Event definition for a given time-series 
physiological output (in this case ICP). A threshold 
crossed for a specific period (the hold-down) indicates that 
an event has started. Clear hold-down indicates that the 
event has finished. Also shown are a treatment at a 
specific time-point and a time window overlaid for 
association of that treatment with the event. 
The other components of the framework concern 
the use of process models, which are a construct 
borrowed from the field of business process 
management – most commonly used to describe 
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real-world problems of project management and 
corporate efficiency. There have been projects where 
process models have been applied to medical 
problems, but these appear to mainly concern the 
administration and logistics of hospitals and other 
large-scale corporate structures (where the fact that 
these structures are medical in nature is largely 
incidental). 
Similar in nature to flow-charts, a process model 
is a directed or undirected graph with a collection of 
edges and nodes. They can be expressed using 
various notations, each with slightly different 
characteristics - e.g. UML (www.uml.org) or BPMN 
(Chinosi & Trombetta 2012). Depending on the 
notation used, the edges and nodes represent various 
actions and states that can be generalised to the 
specific context being described (in this case, the 
medical output observed from a neurological ICU 
bedside machine). 
The translation to a process model in this work 
comes from two sources: evaluation of an event log 
for the physiological/treatment data and the 
evaluation of semantic text from the guideline. This 
latter source is a manual step in this work, and is 
similar to the work of “semantic web” 
interpretations of medical text information (Kaiser & 
Miksch 2009). Comparison of the two resulting 
process models builds on the work conducted in 
(Dijkman et al. 2009), with the notions of similarity 
encapsulated by the similarity of individual nodes 
and edges combined with relevant weighting to 
represent the significance of certain aspects. 
To apply these business process analysis tools – 
expression of medical output as process models and 
the use of comparison and distance calculations in 
this context – in this particular way are believed to 
be a unique feature of this work. 
3 RELATED LITERATURE 
A review of related literature covers several areas: 
issues of adherence to clinical guidelines in general 
and specifically in the TBI domain, novel attempts 
to improve adherence, and the relevance and utility 
of the chosen technology. 
3.1 Clinical/TBI Guideline Adherence 
Issues of communication appear as a common thread 
when evaluating adherence to clinical guidelines. 
(Ansari et al. 2003) looked at beta-blocker use in 
heart failure and showed various methods and 
channels of disseminating the guideline information. 
These were to use a nurse facilitator (direct 
intervention by trained specialist), general education 
(documents, leaflets, etc) and clinical reminders 
(automated interventions). These all had different 
effects on adherence, with the nurse facilitator being 
the most successful. (Rood et al. 2005) indicated that 
a study of glucose measurement and regulation 
improves greatly when dissemination is provided 
through computer-assisted means rather than 
through paper-based means.  
A systematic review of guideline dissemination 
strategies (Prior et al. 2008) showed that the (non-) 
effectiveness of passive dissemination is a 
significant result. Similar to the (Ansari et al. 2003) 
study, where direct intervention is taken by a person 
or automated method, the adherence rate is markedly 
better than if the guideline document and 
information is published passively (e.g. using 
conferences, websites or didactic lectures).  
Other studies (Grol 2016) similarly show that 
targeted and behaviourally “disruptive” methods are 
best for disseminating information and influencing 
clinical practice. Therefore, understanding the 
effectiveness of these different methods of 
dissemination is an important factor in developing 
tools to improve awareness and therefore adherence. 
When considering TBI specifically, the gold 
standard in guidelines is the 1994 Brain Trauma 
Foundation (BTF) initiative to formulate treatments 
for brain injury, which have since become 
standardised, internationally-recognised guidelines 
(Bullock et al. 1996). Several studies have been 
conducted that show dropping mortality rates and 
improved long-term outcomes since the adoption 
and spread of use of these guidelines (Bratton & 
Chestnut 2006). In the last decade, this improvement 
in TBI management has continued, leading to 
studies indicating that overall improvements in 
outcome due to adherence to the BTF guidelines 
have also been apparent (Tarapore et al. 2016) and 
in similar studies conducted four years apart (Ghajar 
2000) and (Fakhry et al. 2004). 
However, significantly, adherence to the BTF 
guidelines is not universal – many studies outline 
their potential deficiency in various aspects such as 
hypothermia (Clifton et al. 2001) and the need for 
ICP monitoring (Chesnut et al. 2012).  
3.2 Novel Attempts to Improve 
Adherence 
Evident from this discussion is the fact that 
guideline adherence is subject to great variation. 
There are many reasons for non-adherence, but these 
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can be broken down into two broad categories: being 
unwilling to adhere to a guideline and being unable 
to adhere. Whilst techniques to address the first 
category include improved dissemination, 
communication and various long-term social 
methods, improvements in the second category, 
which is usually functional in nature (e.g. lack of 
resources/time), can be approached using 
“behaviourally disruptive” methods. 
Most attempts to improve adherence to 
guidelines in the medical domain involve a direct 
change or implementation of a care procedure. In 
these cases, the evidence-base for a guideline comes 
from a panel of experts in the field that have reached 
a point of consensus for various treatments. The 
novel attempts then concern the implementation of 
that guideline in patient care in a standardised and 
accountable way. 
A campaign that exemplifies this approach is 
“Surviving sepsis”, which has looked at targeted 
improvement of patient care by specifically 
supporting guideline adherence through the 
identification of resuscitation and management 
“bundles”. Part of this was an intensive data 
collection arm, which – in real-time – forced 
clinicians to systematically add data as part of 
clinical routine (Levy et al. 2010). The results of this 
have shown a marked improvement in adherence to 
the guidelines, but an emergent complication was 
the ability to stay current with the latest guidelines 
and update procedures to reflect this. Feedback from 
the first four years of this project back into the re-
development and improvement of sepsis guidelines 
has been cautiously optimistic (Dellinger et al. 
2013). Whilst not specifically providing a new type 
of analysis it does provide a large canon of data for a 
specific condition that is potentially useful for future 
studies into sepsis as well (Lehman et al. 2011). 
A study looking at the ability to change 
behaviour where possible when implementing 
guidelines (Grol & Grimshaw 2003), has shown that 
only comprehensive interventions on all levels of 
input and with specific targets and barriers identified 
stand a chance of influencing behaviour. Several 
categories were identified: educational strategies, 
audit and feedback, use of reminders/computers, 
substitution of tasks, multi-professional 
collaboration, mass media campaigns, total quality 
management, financial incentives, patient-mediated 
interventions, and a combination of all of these 
interventions. This was a broader conclusion than 
that reached by (Ansari et al. 2003) on a similar 
study (which described active rather than passive 
interventions being more effective). 
Improvements in mobile technology have also 
further advanced the ability to implement guideline 
adherence, as the proximity to the end user (be they 
patient or clinician) allows immediate and real-time 
intervention or consultation. Examples of patient 
interventions include the development of the 
MobiGuide project (Shalom et al. 2015), and other 
quality of life applications that allow quick reference 
in the form of either notifications (e.g. a message to 
a patient to take their medication) or input (e.g. a 
daily symptom diary that a patient can fill in) which 
allows the direct consequences of adherence or non-
adherence to be measured. An example of adherence 
improvement tools directed at clinicians include the 
development of the SIGN apps 
(www.sign.ac.uk/sign-apps.html), which provide 
immediate triage information across many 
emergency fields, allowing doctors to quickly 
consult their actions with regard to the official 
guidelines in this field. 
3.3 Framework Technology 
It can be seen that many novel technologies exist, 
but for the purposes of choosing an applicable 
technology to address the particular challenges in 
this work, many of the characteristics appear to be 
well represented by processes and work-flows, and 
hence the slightly wider speciality of process 
models. 
(Perimal-lewis et al. 2012) claims that the 
fundamental element required for the construction of 
a process model is the historical event log of a 
process, and this lends itself to the description of 
actions and reactions in a medical context. This 
research area is referred to “process mining” and is 
usually applied to the logistical higher-level patient 
care work-flows within a hospital. Studies, such as 
(Mans & Schonenberg 2009), investigate the 
different management processes using various 
process mining views on control-flow structures, and 
how these affect organisation and performance 
within a hospital. 
This area is also related to the more general 
domain of business process management (BPM) not 
usually realized as medical processes, but critical in 
the use of event/reaction flow-diagrams to formally 
describe processes that occur within complex 
organisations. An example of this is (Werf et al. 
2012), which looks at tools to automate the 
compliance of an business to specific guidelines, 
typically referred to as “audit”. The idea behind this 
work is to develop an awareness of the context of a 
process, which can often impact the perceived 
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compliance to a guideline, without being sufficiently 
accounted for in the evaluation. Work such as this 
however, does tend to exist in abstract discussions, 
and rarely gets implemented in a real hospital 
setting. 
There is also a discrepancy between the level of 
pattern extraction and the focus on the level of 
patterns. The process mining work referred to above 
nearly always focuses on the clinician behaviour as 
part of a corporate body, with a view to improving 
those corporate processes such as (Perimal-lewis et 
al. 2012). At a lower “micro” level, pattern 
extraction science focuses on mathematical 
techniques to detect individual events (again, similar 
to and possibly driven by signal processing). The 
connection between these two levels, which is where 
the work proposed in this document is focused, is 
rare, though it does exist. (Huang et al. 2012) looks 
at the “clinical pathway” area, where a clinical event 
log is analysed and common remedial medical 
behaviours are extracted. The work was validated by 
clinical experts as a true representation of some of 
their behaviours, but it did conclude that the general 
nature of the conclusions, meant that more specific 
work was required, and that some critical behaviours 
were missed. 
This is where the focus on a specific condition 
helps in identifying processes more exactly and in a 
way that is immediately useful to clinicians working 
in the ICU. 
4 SYSTEM ARCHITECTURE 
The highest level schematic of the proposed 
technical solution in this work can be seen in figure 
1 (section 2.2). This shows the broadest steps to 
achieve a measure of guideline adherence: 
1. Convert the raw physiological and treatment 
data into an event log 
2. Convert the event log into a process model 
3. Convert the text guidelines into a similarly 
structured process model 
4. Compare the two and calculate the distance 
between them (this is the measure of non-
compliance, the inverse of which is adherence, 
the overall goal) 
The architectural and design details are now 
expanded upon in this section. 
4.1 Process Model from 
Physio/Treatment Data 
The conversion of the physiological and treatment 
data into a set of event logs has been conducted 
using the EUSIG event parameter definitions. As 
mentioned in section 2.2, the major detail of this 
work for one of the data-sets used here can be found 
in (Stell et al. 2014). 
In summary, the work was an audit of pressure 
events (specifically ICP and CPP) through-out the 
Brain-IT data-set (Piper et al. 2010) (see section 5 
for a summary description of this data), using pattern 
matching techniques where the EUSIG definition of 
ICP or CPP event was the target pattern within the 
data-set (for all pattern definitions the structure was 
the same – see figure 2 – but the parameter values, 
such as threshold and hold-down time were varied). 
 
Figure 3: E-R diagram of the standardised interface – the 
“treatment profile” database – for compiling physiological 
and treatment data from ICU data-sets, ready for 
conversion to logical event logs. 
The overall results of this conversion work 
outlined some interesting clinical results, such as the 
verification of an “unofficial” event threshold of 15 
mmHg when clinicians feel they must intervene to 
manage an escalating ICP (also known as an 
intracranial hypertensive episode). But the practical 
data output was a generalised accumulation of 
information about ICP and CPP events, alongside 
treatment information. 
After this audit work had been concluded, the 
next logical step was realised in storing this data 
representation in a standardised interface, so that 
future data-sets could be compared in a similar way. 
Currently this standardised interface is implemented 
in a MySQL database (known as the “treatment 
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profile” database), the entity-relationship diagram 
(and hence schema) can be seen in figure 3. 
From this “treatment profile” database, a logical 
representation of an event log can be drawn, which 
will then be converted into a process model. (Note: 
when considering the definition of an “event” in the 
terms supporting the development of a process 
model, the log actually encompasses both the 
pressure events and the application of treatments). 
The implementation of the process models 
involved at this stage can be considered as a set of 
elements indicating an “event” taken at any one time 
(the most useful temporal measure deemed to be 
minute-by-minute). So using a combination of the 
event, any treatments falling within the time 
window, a “guideline object” is created that 
indicates what those elements are at a given minute 
due to the actual actions that have occurred in the 
ICU. In the next section a similar set of objects are 
constructed, which form the ideal actions that would 
have occurred if the guidelines had been followed 
exactly. 
4.2 Process Model from Guidelines 
The conversion of BTF guidelines to a process 
model requires more manual interpretation and 
implementation than the conversion from the ICU  
data. Some semantic processing technologies were 
considered to achieve this, but were considered 
unnecessary once the specific guidelines were listed, 
as the conversion process turned out to be relatively 
simple. There are 15 severe traumatic brain injury 
guidelines (for severe in-hospital treatment) 
covering various types of injury and treatment 
(www.tbiguidelines.org). Of these, the four that 
were specifically looked at (due to their relevance to 
the management of ICP and CPP) were: 
 
▪ #1 – Blood pressure and oxygenation 
▪ #2 – Hyperosmolar therapy 
▪ #8 – Intracranial pressure thresholds 
▪ #9 – Cerebral perfusion thresholds 
An example of text that required translation was 
guideline #9 which had several conditions relating to 
the threshold of CPP where treatment must be 
applied, dependent on the presence (or not) of 
cerebral autoregulation (the feedback mechanism 
that protects the brain for a limited time when blood 
flow is impaired). The guideline text reads: 
 
▪ “Aggressive attempts to maintain cerebral 
perfusion pressure (CPP) above 70 mm Hg with 
fluids and pressors should be avoided because 
of the risk of adult respiratory distress 
syndrome (ARDS)” 
▪ “CPP of <50 mm Hg should be avoided” 
▪ “The CPP value to target lies within the range 
of 50-70 mm Hg. Patients with intact pressure 
autoregulation tolerate higher CPP values” 
▪ “Ancillary monitoring of cerebral parameters 
that include blood flow, oxygenation, or 
metabolism facilitates CPP management” 
When converting this to a process model, the 
model was chosen to be expressed in business 
process model notation (BPMN). Figure 4 shows 
how these text bullet points translate to this notation. 
 
Figure 4: BPMN chart showing the representation of the 
CPP guideline (BTF #9). 
Similar BPMN diagrams were compiled for the 
other guidelines (#9 being the most complex) and 
then related to the process model drawn from the 
raw ICU data. 
In terms of how the information from the 
physio/treatment stream relates to this example, the 
most important information captured is the presence 
of a threshold-crossing in the CPP read-out. This 
indicates the beginning of a CPP pressure event and 
the start of the cycle denoted in figure 4. Ancillary 
monitoring and autoregulation status are stored in 
other clinical monitoring parameters, with the 
treatment applied stored in the treatment profile 
database. The treatment profile database is searched 
for this combination of event and treatment. The red 
box in figure 4 denotes a detail about the type of 
treatment: if the patient is highly loaded with 
pressors already then a water treatment is mandated, 
as well as vice versa. Therefore the process model 
checks for the type as well as the presence of a 
treatment. 
The process models are therefore compiled by 
listing the relevant nodes and graphs (e.g. treatment 
presence, type, and response time and their sequence 
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in time in relation to each other). To re-state again: 
one is generated for the actual timeline from the 
treatment profiles database, which is a model 
representing what happened in the ICU. And the 
other – drawn from the guideline - represents the 
ideal timeline and shows what the ideal clinical 
response would have been given the context of 
events, patient situation, etc. 
4.3 Similarity Calculations 
These two process models can now be compared, 
and the distance calculation chosen builds on the 
work conducted by (Dijkman et al. 2009). In this 
paper a distance between two business process 
models is calculated using several different 
algorithms and representations of the models 
themselves. The fundamental calculation presented 
comes down to a weighting attached to the different 
nodes and edges, then a calculation of how many 
transitions the first model needs to make in order to 
reach the same state as the second model.  The 
different distances calculated include string-edit 
distance (nodes only) and graph-edit distance (nodes 
and edges). The distances between the process 
models presented are calculated using four different 
algorithms, each with different characteristics that 
trade-off between completeness and efficiency: 
“Greedy”, ”A-star”, ”Process heuristic”, 
“Exhaustive”. The conclusion of the paper is that the 
“Greedy” algorithm (searching for local optima) and 
“A-star” (a well-known shortest distance algorithm) 
were the best performing in terms of speed versus 
acceptable completeness (“A-star” being slightly 
slower but more accurate). 
To build on and apply these methods to the 
guideline adherence work in this paper, the simplest 
methods were initially chosen, corresponding to the 
“string-edit distance” used in (Dijkman et al. 2009). 
These include two algorithms which have a simple 
direct comparison with no weighting added to the 
nodes (“Direct”) and one with node-weighting added 
(“Weighted”).  
4.4 Clinical Result Presentation 
Using these distance calculations, the final number 
of adherence is generated. They are presented in two 
categories: level of non-adherence (expressed as a 
percentage) and the duration of these levels of non-
adherence (in minutes). However, to apply real 
clinical relevance to these numbers, the factors must 
be considered in combination. Figure 5 shows a 
square with four quadrants indicating severity when 
considering non-adherence level against duration, 
similar to those used for risk analysis. In the bottom 
left quadrant, we have deviations that are of a low 
level for a short time (the least significant clinical 
scenario). In the top right, are deviations that are of a 
high level for a long time (the highest significance). 
The opposing quadrants indicate a mid-range of 
significance. Therefore two combinatorial metrics 
indicate approximately where on this quadrant the 
output sits: 
 
▪ Duration / Non-adherence (A) 
▪ Duration * Non-adherence (B) 
The clinical analogue of these combinations is 
that if A is very high or very low, the severity 
occupies either of the two mid-range quadrants. If A 
tends to 1, then it is either in the least or most 
significant quadrants. To ascertain which of these 
latter quadrants the output occupies, B indicates 
either high (most significant) or low (least 
significant). Testing where the thresholds of these 
limits occur will be follow-up work (see discussion 
section). 
 
Figure 5: Quadrants of severity that provide a clinical 
interpretation of the non-adherence and duration numbers. 
5 RESULTS 
The results in this section show the adherence output 
when the system is run against a real neurological 
ICU data-set. The data-set is the Brain-IT database 
(Piper, Chambers, Citerio, Enblad, Gregson, 
Howells, Kiening, Mattern, Nilsson & Ragauskas 
2010): a compilation of 262 brain-injured patients 
collected over a period of three years from 2003-
2006, across 22 specialist neurological ICU centres 
in Europe.  
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Output corresponding to the two clinically-
relevant categories is shown: non-adherence 
measurements on a minute-by-minute basis over 
single pressure events and aggregate information 
about non-adherence and duration over all pressure 
events occurring in individual patient stays. 
The relative weightings used for non-adherence 
factors are: 0.25 for repeat pattern treatment non-
adherence, 0.5 for a type non-adherence and 1.0 for 
treatment outside the time window. 
5.1 Minute-by-minute 
The clinical analogue to measuring adherence on a 
minute-by-minute basis would be that of a real-time 
monitor, allowing a clinician to know immediately 
where the patient’s clinical context lies in relation to 
the official guideline. In the framework built for this 
work an example of this output is shown in figure 6. 
 
Figure 6: Minute-by-minute read-out of guideline 
adherence for a single pressure event on one patient using 
the direct algorithm. 
In this example the time-window of response 
mandated by the guideline is 15 minutes as an 
acceptable clinical response time. In figure 6 the 
blue line indicates the trace of physiological series 
(in this case mean ICP), with flags indicating 
treatments administered by the clinician during the 
course of the event. The red line indicates the non-
adherence level at that immediate minute. It can be 
seen that two non-adherence values dominate the red 
line: 25% and 50%. The total output for this patient 
– all events, therefore more than the single event 
shown in figure 6 – is shown in tables 1 and 2 
(corresponding to the use of the direct and weighted 
algorithms respectively). 
 
 
 
 
 
Table 1: Total duration and non-adherence levels for 
patient 15026161, along with qualitative reasons for non-
adherence (“direct”). 
Total 
duration 
(mins) 
Non-
adherence 
(%) 
Reason(s) 
42 25.0 - Treatment should be 
part of repeat pattern 
708 50.0 - Treatment not 
administered within 
time window 
- Treatment should be 
part of repeat pattern 
 
In both tables, the reasons that make up these 
non-adherence values are two-fold: “Treatment 
should be part of a repeat pattern” and “Treatment 
not administered within time window”. The 
difference between the two tables relates entirely to 
the numbers resulting from the different scales 
assigned to each reason. Therefore with a factor 0.25 
assigned to the repeat pattern treatment, the levels of 
non-adherence skew in either direction (the lower 
number decreases significantly from 25% to 6.25%, 
whilst the higher number increases slightly from 
50% to 56.25%). To develop this as a useful clinical 
tool, would require a survey of domain experts to 
find a common consensus on what weighting values 
should be attached to each reason. Or expressed 
another way: how important is each reason in 
relation to each other? 
Table 2: Total duration and non-adherence levels for 
patient 15026161, with qualitative reasons for non-
adherence (“weighted”). 
Total 
duration 
(mins) 
Non-
adherence 
(%) 
Reason(s) 
42 6.25 - Treatment should be 
part of repeat pattern 
708 56.25 - Treatment not 
administered within 
time window 
- Treatment should be 
part of repeat pattern 
Also notable between tables 1 and 2 is that the 
structural information output remains unchanged 
(the duration size and the number/nature of the non-
adherence reasons). This intuitively makes sense as 
the only difference between the two algorithms is 
one of scale due to the differently weighted factors. 
As the work develops to include distance 
calculations between edge directions as well as node 
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size, it is anticipated that there may be structural 
differences to evaluate (see discussion section). 
Table 3: Total duration and non-adherence levels for 
patient 26138384, with qualitative reasons for non-
adherence (“weighted”) including contraindication due to 
treatment type. 
Total 
duration 
(mins) 
Non-
adherence 
(%) 
Reason(s) 
17 18.75 - Treatment type 
contraindicates in 
patient context 
- Treatment should be 
part of repeat pattern 
483 56.25 - Treatment not 
administered within 
time window 
- Treatment should be 
part of repeat pattern 
 
Table 3 shows another patient that has similar 
non-adherence levels due to the dominant factors of 
treatments outside of the time window and repeat 
patterns. However, there is an additional factor of 
“treatment type contraindicates in patient context”, 
which adds a different number to the deviation 
amount (in this case 18.75%, as treatment type has a 
weighting of 0.5). This has come about as the patient 
has been administered steroids when the load is 
already high, which is an aspect that this guideline 
(#9) mandates against. 
5.2 Single Patient Stay 
The second category to consider is the non-
adherence levels over an entire patient stay. The 
clinical utility of this is to gain an understanding of 
how non-adherence relates to the management of 
individual pressure events given a patient’s clinical 
context. To this end aggregated output is compiled 
for the individual patients. Total information for 
patients 15026161 and 26138384 are already shown 
in tables 1, 2 and 3 but more detailed statistics on the 
non-adherence and duration for each patient (using 
the “weighted” algorithm) are shown in tables 4 and 
5. For each of these patients, an inter-quartile range 
is calculated to understand the range and spread of 
the data. An obvious point of interest from the non-
adherence level is how much the non-adherence 
level skews towards the maximum level of 56.25% 
 
 
 
Table 4: Spread and central tendency calculations for non-
adherence level, duration, duration/non-adherence (A), 
and duration * non-adherence (B) using the “weighted” 
algorithm for patient 15026161. 
 
 
The clinical interpretation of these results is 
potentially broad, but a first step is to check the 
mean values against the quadrants outlined in figure 
5. For patient 15026161, the duration/non-adherence 
(A) is 4.63 and the duration * non-adherence (B) is 
10014.06. Assuming both of these figures to be 
considered “large” – which in the case of A means 
that the ratio is significantly higher than 1 – would 
put the overall impact of these deviations into the 
mid-range quadrant close to the border of “most 
significant”. When looking at the detailed output of 
individual deviations, this could be interpreted as the 
analogue of many “small” deviations (due to the 
non-administration of treatments in timely manner) 
adding up to a significant impact on management of 
ICP events. Table 5 shows a similar table for the 
patient 26138384, where the mean value of (A) is 
significantly lower than a ratio of 1 and the mean 
value is an order of magnitude lower than 15026161 
therefore the relative non-adherence potentially 
indicates a lower impact. 
Table 5: Spread and central tendency calculations for non-
adherence level, duration, duration/non-adherence (A), 
and duration * non-adherence (B) using the “weighted” 
algorithm for patient 26138384. 
 
6 DISCUSSION 
The output of the spread and central tendency 
information in the interquartile range tables (4 and 
5) indicate the dominance of a particular set of non-
adherence reasons (“treatment not administered 
within time window” and “treatment not part of 
repeat pattern”). This is very likely due to the low 
annotation level of this data-set, which in turn is 
linked to the age of the data-set (itself a pioneering 
effort in neurological ICU data collection at the turn 
of the millennium). The next step in this research is 
to run the same validation test over several more 
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modern data-sets, three of which have been 
identified and will be available for further work very 
shortly (the CSO project data for the identification 
of artefactual data in neurological ICUs, the ICCA 
system data from the Queen Elizabeth University 
Hospital ICU, Glasgow, and MIMIC III (Saeed 
2007)). These are similarly representative of 
different aspects of the neurological ICU – CSO 
indicates a physical check on treatment information 
supplied by computer (an observer notes whether a 
treatment was actually delivered at the time the 
computer indicates), ICCA is one of the latest 
software frameworks in neurological ICUs, and 
MIMIC III is a compilation of data from 2008 to 
2013 on non-specialist ICU information from around 
the USA. Not only will the output of using these 
data-sets provide further valuable information on the 
validity of the approach in this paper, but will 
provide accuracy checks of different steps along the 
process of compilation. 
Similarly, a consensus check against domain 
experts will be performed in order to match the 
output from this work against what is considered 
“typical” reactions in a neurological ICU. From this 
comparison, it would be hoped that the notion of 
scaling of the weighted nodes would give an 
indication of how important the different clinical 
factors are and how this affects the quantitative 
output when combined with other factors. An 
indication of the thresholds on figure 5 indicating 
the difference between different regions of severity 
could be ascertained through a similar process. An 
interesting study would be a real-time output of a 
clinician (e.g. recording a verbal commentary of 
actions taken as they are occurring) to compare 
against the evaluation occurring in the work. 
However the difficulties of achieving enough data 
beyond a small sample for this type of study – due to 
privacy and ethical concerns – may be too 
challenging. 
Another strand that will be expanded on shortly 
will be the usage of the more sophisticated distance 
comparison algorithms posited by (Dijkman et al. 
2009). It is assumed that structural distance 
calculations – “graph-edit similarity” in the language 
of that work – will affect the structural output of the 
non-adherence and duration, which would be visible 
in the results for a single patient run over several 
different algorithms. The statistical significance of 
this difference will be calculated then verified 
against the experience of domain experts.  
Finally, whilst the output can guide real-time 
immediate clinical reaction, and give information on 
pressure event management, it is hoped that with the 
same metrics taken over all patients in all data-sets, 
and linked to clinical outcome, the quantitative 
measures of non-adherence could inform studies that 
contribute to official guideline development. This 
work is currently underway and makes use of the 
(highly unusual) aspect of the Brain-IT data-set 
capturing patient outcome, measured using the 
Glasgow Outcome Scale, at 6-months post-injury. 
7 CONCLUSIONS 
Presented in this work are the preliminary results 
from an automated system constructed to use data 
that is currently available in many high-dependency 
neurological ICUs. The central framework uses 
simple process model technology to interpret data 
from two sources (bedside physio/treatment data and 
text guidelines) and use these to compare and add 
quantitative value. The output presents information 
in a variety of ways to gain detailed insight into the 
duration and nature of non-adherence to mandated 
guidelines that has the potential to aid immediate 
real-time clinical response, as well as aggregated 
study information to provide feedback on pressure 
event management. 
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